This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ICAD To Showcase Its Platform Of Computer-Aided Detection And Advanced Imaging Solutions At RSNA Annual Meeting

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will showcase its suite of Computer-Aided Detection (CAD) and advanced imaging solutions at the Radiological Society of North America (RSNA) 99 th Annual Meeting being held December 1-6, 2013 in Chicago. iCAD will feature the SecondLook ® CAD technology for the identification of breast cancer, including the PowerLook ® Advanced Mammography Platform ® featuring iCAD partner Mātakina’s VolparaDensity volumetric breast density assessment software. iCAD’s VeraLook ®, a revolutionary CAD solution for virtual colonoscopy (CTC) designed to enhance clinician accuracy and effectiveness by improving detection of colonic polyps, will also be on display.

“The robust display of CAD and imaging solutions showcased in our booth at this year’s RSNA are a testament to iCAD’s proven history and long-time leadership position in the radiology space,” said Ken Ferry, President and CEO of iCAD. “iCAD remains committed to the continued development of advanced technologies, like CAD for 3D tomosynthesis, to meet the needs of our more than 4,800 customers as well as delivering cost-effective, innovative solutions that help radiologists detect cancers with greater confidence.”

iCAD offers high-performance, upgradeable CAD systems and workflow solutions for mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). PowerLook AMP provides radiologists with the ability to customize their CAD solution to meet the needs of their individual work environment, including the integration of Mātakina’s VolparaDensity assessment solution, an FDA-cleared technologic advancement providing volumetric breast density measurements that correlate to the BI-RADS breast density category to assist in interpreting digital mammograms. The technology expands on iCAD’s SecondLook Digital algorithm and the CAD metrics feature provides a rich set of clinical decision support tools to aid in mammography screening. Shown to be effective in the detection of colonic polyps, iCAD’s VeraLook CAD solution is designed to integrate with specialized CTC reading environments to streamline the reading process and improve clinician accuracy, productivity, and workflow.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.76 -0.51%
FB $118.12 0.26%
GOOG $704.58 0.45%
TSLA $210.46 -0.51%
YHOO $36.84 -0.27%


Chart of I:DJI
DOW 17,601.85 -58.86 -0.33%
S&P 500 2,041.39 -9.24 -0.45%
NASDAQ 4,687.7910 -29.3030 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs